Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 9/20 | 0.40 |
| ▸ | ELANE | P08246 | 1/20 | 0.35 |
| ▸ | APEX1 | P27695 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5841679 | 0.85 | PDK2 (0.43) | PDK2ELANEAPEX1CYP1A2CYP3A4 | |
| SCHEMBL25750220 | 0.82 | PDK2 (0.38) | PDK2APEX1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL14073162 | 0.82 | KDM4E (0.35) | PDK2CYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL17678560 | 0.82 | PDK2 (0.42) | PDK2APEX1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL10018628 | 0.81 | PDK2 (0.41) | PDK2APEX1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL17680057 | 0.81 | PDK2 (0.41) | PDK2APEX1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL14073161 | 0.81 | — | — | |
| SCHEMBL17678567 | 0.81 | PDK2 (0.41) | PDK2APEX1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL27746525 | 0.81 | PDK2 (0.40) | PDK2APEX1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL28781068 | 0.80 | PDK2 (0.40) | PDK2ELANEAPEX1CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9911921-B2 | Organic compound and organic light-emitting device | CANON KABUSHIKI KAISHA (JP) | 2018-03-06 | — | — | US | disclosed |
| US-9755165-B2 | Silsesquioxane compound, organic light emitting element, display apparatus, image information processing apparatus, and image forming apparatus | CANON KABUSHIKI KAISHA (JP) | 2017-09-05 | — | — | US | disclosed |
| US-20160118607-A1 | SILSESQUIOXANE COMPOUND, ORGANIC LIGHT EMITTING ELEMENT, DISPLAY APPARATUS, IMAGE INFORMATION PROCESSING APPARATUS, AND IMAGE FORMING APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2016-04-28 | — | — | US | disclosed |
| US-20150372238-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE | CANON KABUSHIKI KAISHA (JP) | 2015-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150372238-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE | ORC3, AOC3, EML4 | PDK2 2731/4885ELANE 2587/4885APEX1 1567/4885 |
| US-20160118607-A1 | SILSESQUIOXANE COMPOUND, ORGANIC LIGHT EMITTING ELEMENT, DISPLAY APPARATUS, IMAGE INFORMATION PROCESSING APPARATUS, AND IMAGE FORMING APPARATUS | SFXN1, LSS, SLC7A5 | PDK2 3593/4885ELANE 3358/4885APEX1 3969/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.